Use access key #2 to skip to page content.
$45.80 1.67 (3.78%)
7/3/2008 1:00 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

3

Avatar leeleming (< 20) Submitted: 9/04/06 3:02 AM : Outperform Start Price: $60.41 AZN Score: -20.23

Solid pipeline and excellent leadership - attracting key talent from major pharma

Report this Post Replies: 0 | Reply

Featured Broker Partners